Merck, Genentech Sold Unapproved Drugs, FCA Suit Says
By Kurt Orzeck (May 11, 2016, 8:41 PM EDT) -- Merck Serono S.A., Genentech and other drug manufacturers are facing qui tam claims that they illegally received reimbursements from the government for unapproved vaccines and other biologic drugs, according to a False Claims Act suit unsealed Wednesday in New York federal court.
The complaint alleges that Merck Serono S.A., Genentech Inc., Amgen Inc., Bayer Schering Pharma AG, Bristol-Myers Squibb and a host of other companies put patients at risk by conspiring with pharmacies and drug-packaging companies to repackage drugs with excess product in violation of approved labeling.
Relator John F. Underwood, a former sales representative for Merck and Genentech, said the...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!